{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:55:34Z","timestamp":1790362534773,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Swedish Armed Forces Research"},{"name":"Technology Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bcp.2013.01.016","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T15:33:58Z","timestamp":1359473638000},"page":"1389-1397","source":"Crossref","is-referenced-by-count":36,"title":["Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: Possible implications for the HI-6 antidote substrate specificity"],"prefix":"10.1016","volume":"85","author":[{"given":"Elisabet","family":"Artursson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Ola","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Akfur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Linusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"B\u00f6rjegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.01.016_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pa.34.040194.001433","article-title":"The cholinesterases:from genes to proteins","volume":"34","author":"Taylor","year":"1994","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0010","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bcp.2013.01.016_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nsb0197-57","article-title":"Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A","volume":"4","author":"Raves","year":"1997","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0020","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/1821672a0","article-title":"Protection by oximes of bis-pyridinium ions against lethal diisopropyl phosphonofluoridate poisoning","volume":"182","author":"Hobbiger","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2013.01.016_bib0025","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tox.2009.09.002","article-title":"Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis","volume":"265","author":"Artursson","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2013.01.016_bib0035","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1021\/ja804941z","article-title":"Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation","volume":"130","author":"Carletti","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bcp.2013.01.016_bib0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/bi051286t","article-title":"Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase","volume":"45","author":"Ekstr\u00f6m","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2006.05.027","article-title":"Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime:structural basis for differences in the ability to reactivate tabun conjugates","volume":"72","author":"Ekstr\u00f6m","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.clpt.6100151","article-title":"Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes","volume":"82","author":"Ekstr\u00f6m","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2013.01.016_bib0055","doi-asserted-by":"crossref","first-page":"9883","DOI":"10.1021\/ja992704i","article-title":"Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad","volume":"121","author":"Millard","year":"1999","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bcp.2013.01.016_bib0060","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1021\/bi982678l","article-title":"Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level","volume":"38","author":"Millard","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0065","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1021\/bi0621361","article-title":"Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state","volume":"46","author":"H\u00f6rnberg","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0926-6593(66)90023-3","article-title":"On the mechanism of aging of phosphonylated cholinesterases","volume":"128","author":"Benschop","year":"1966","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2013.01.016_bib0075","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.154.3747.404","article-title":"Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin","volume":"154","author":"Harris","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.bcp.2013.01.016_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002040050495","article-title":"Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds","volume":"72","author":"Worek","year":"1998","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1107\/S0021889893005588","article-title":"Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants","volume":"26","author":"Kabsch","year":"1993","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.bcp.2013.01.016_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bcp.2013.01.016_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/emboj\/cdg005","article-title":"Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site","volume":"22","author":"Bourne","year":"2003","journal-title":"Embo J"},{"key":"10.1016\/j.bcp.2013.01.016_bib0100","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bcp.2013.01.016_bib0105","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bcp.2013.01.016_bib0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.bcp.2013.01.016_bib0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0263-7855(90)80070-V","article-title":"WHAT IF: a molecular modelling and drug design program","volume":"8","author":"Vriend","year":"1990","journal-title":"J Mol Graphics Modell"},{"key":"10.1016\/j.bcp.2013.01.016_bib0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi,psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.bcp.2013.01.016_bib0125","unstructured":"DeLano WL. (2002) The PyMOL Molecular Graphics System."},{"key":"10.1016\/j.bcp.2013.01.016_bib0130","first-page":"610","article-title":"Site selectivity of fluorescent bisquaternary phenanthridinium ligands for acetylcholinesterase","volume":"31","author":"Berman","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0135","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bi00680a029","article-title":"Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding","volume":"14","author":"Taylor","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0140","first-page":"93","article-title":"Interaction between bisquaternary ammonium ligands and acetylcholinesterase: complex formation studied by fluorescence quenching","volume":"10","author":"Taylor","year":"1974","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0145","first-page":"703","article-title":"Propidium \u2013 a fluouresence probe for a peripheral anionic site on acetylcholinesterase","volume":"10","author":"Taylor","year":"1974","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0150","doi-asserted-by":"crossref","first-page":"e5957","DOI":"10.1371\/journal.pone.0005957","article-title":"Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and design","volume":"4","author":"Ekstr\u00f6m","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2013.01.016_bib0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cbi.2010.04.014","article-title":"Interaction kinetics of oximes with native, phosphylated and aged human acetylcholinesterase","volume":"187","author":"Radic","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2013.01.016_bib0160","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1021\/jm900433t","article-title":"Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime","volume":"52","author":"Sanson","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2013.01.016_bib0165","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2010.05.022","article-title":"Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds","volume":"80","author":"Wille","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0170","article-title":"A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds","author":"Maxwell","year":"2012","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2013.01.016_bib0175","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1021\/jm901853b","article-title":"Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation","volume":"53","author":"Carletti","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2013.01.016_bib0180","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/bi020143t","article-title":"The aromatic \u201ctrapping\u201d of the catalytic histidine is essential for efficient catalysis in acetylcholinesterase","volume":"41","author":"Barak","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0185","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1021\/bi030206n","article-title":"Is aromaticity essential for trapping the catalytic histidine 447 in human acetylcholinesterase?","volume":"43","author":"Kaplan","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2013.01.016_bib0190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jat.1084","article-title":"Effective bisquaternary reactivators of tabun-inhibited AChE","volume":"25","author":"Kuca","year":"2005","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.bcp.2013.01.016_bib0195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/355472a0","article-title":"Free R value: a novel statistical quantity for assessing the accuracy of crystal structures","volume":"355","author":"Brunger","year":"1992","journal-title":"Nature"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T23:53:13Z","timestamp":1539906793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0006295213000531"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.01.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}